X4 Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 06:42 am EDT
X4 Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 55.71 million compared to USD 21.21 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.6 a year ago.
For the six months, net loss was USD 79.73 million compared to USD 43.18 million a year ago. Basic loss per share from continuing operations was USD 0.51 compared to USD 1.31 a year ago.